NDC 49281-215

TENIVAC

Clostridium Tetani Toxoid Antigen (formaldehyde Inactivated) And Corynebacterium Diphtheriae Toxoid Antigen (formaldehyde Inactivated)

TENIVAC is a Intramuscular Injection, Suspension in the Vaccine category. It is labeled and distributed by Sanofi Pasteur Inc.. The primary component is Clostridium Tetani Toxoid Antigen (formaldehyde Inactivated); Corynebacterium Diphtheriae Toxoid Antigen (formaldehyde Inactivated).

Product ID49281-215_27f99b25-f744-4640-9f8c-06a4c92bd9e4
NDC49281-215
Product TypeVaccine
Proprietary NameTENIVAC
Generic NameClostridium Tetani Toxoid Antigen (formaldehyde Inactivated) And Corynebacterium Diphtheriae Toxoid Antigen (formaldehyde Inactivated)
Dosage FormInjection, Suspension
Route of AdministrationINTRAMUSCULAR
Marketing Start Date2010-12-08
Marketing CategoryBLA / BLA
Application NumberBLA103171
Labeler NameSanofi Pasteur Inc.
Substance NameCLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
Active Ingredient Strength5 [Lf]/.5mL; [Lf]/.5mL
Pharm ClassesActively Acquired Immunity [PE], Actively Acquired Immunity [PE], Diphtheria Toxoid [CS], Inactivated Clostridium Tetani Vaccine [EPC], Inactivated Corynebacterium Diphtheriae Vaccine [EPC], Tetanus Toxoid [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]
NDC Exclude FlagN
Listing Certified Through2024-12-31

Packaging

NDC 49281-215-10

10 VIAL, SINGLE-DOSE in 1 PACKAGE (49281-215-10) > .5 mL in 1 VIAL, SINGLE-DOSE (49281-215-58)
Marketing Start Date2010-12-08
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 49281-215-10 [49281021510]

TENIVAC INJECTION, SUSPENSION
Marketing CategoryBLA
Application NumberBLA103171
Product TypeVACCINE
Billing UnitML
Marketing Start Date2010-12-08

NDC 49281-215-88 [49281021588]

TENIVAC INJECTION, SUSPENSION
Marketing CategoryBLA
Application NumberBLA103171
Product TypeVACCINE
Billing UnitML
Marketing Start Date2016-02-26

NDC 49281-215-15 [49281021515]

TENIVAC INJECTION, SUSPENSION
Marketing CategoryBLA
Application NumberBLA103171
Product TypeVACCINE
Billing UnitML
Marketing Start Date2010-12-08

NDC 49281-215-58 [49281021558]

TENIVAC INJECTION, SUSPENSION
Marketing CategoryBLA
Application NumberBLA103171
Product TypeVACCINE
Billing UnitML
Marketing Start Date2016-02-26

Drug Details

Active Ingredients

IngredientStrength
CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)5 [Lf]/.5mL

Pharmacological Class

  • Inactivated Clostridium Tetani Vaccine [EPC]
  • Actively Acquired Immunity [PE]
  • Vaccines
  • Inactivated [CS]
  • Tetanus Toxoid [CS]
  • Inactivated Corynebacterium Diphtheriae Vaccine [EPC]
  • Actively Acquired Immunity [PE]
  • Vaccines
  • Inactivated [CS]
  • Diphtheria Toxoid [CS]

Trademark Results [TENIVAC]

Mark Image

Registration | Serial
Company
Trademark
Application Date
TENIVAC
TENIVAC
85269746 4301934 Live/Registered
Sanofi Pasteur Limited/Sanofi Pasteur Limitee
2011-03-17
TENIVAC
TENIVAC
78311948 not registered Dead/Abandoned
SANOFI PASTEUR LIMITED/SANOFI PASTEUR LIMITEE
2003-10-10
TENIVAC
TENIVAC
77144747 not registered Dead/Abandoned
Sanofi Pasteur Limited/Sanofi Pasteur Limitee
2007-03-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.